Actively Recruiting
Epidemiological Survey and Follow-up of Cardiovascular-Kidney-Metabolic Diseases Among Adults in Shanghai
Led by Shanghai Changzheng Hospital · Updated on 2025-09-08
4094
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting a long-term observational study to follow up on the STONE cohort established in Shanghai between 2016 and 2017. This study aims to update information on cardiovascular, kidney, and metabolic outcomes among adult community residents aged 18 to 65 years. It will also compare metabolic risk factors and clinical outcomes between the initial baseline assessment and the follow-up period, exploring how changes in risk factors relate to health outcomes. Participants previously enrolled in the STONE cohort underwent extensive baseline evaluations, including questionnaires, interviews, physical exams, and clinical tests covering lifestyle habits, metabolic indicators, and ultrasound imaging. The follow-up study will categorize participants based on chronic kidney disease staging and continue data collection through June 2026, with the follow-up phase extending until 2035. During the study, participants will have assessments to track the development of cardiovascular diseases and metabolic disorders over about ten years. Researchers will monitor outcomes such as disease occurrence and changes in metabolic factors. The study includes safety monitoring and ongoing data updates to understand long-term health trends in this population over more than a decade of follow-up.
CONDITIONS
Brief Title
Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens
Who Can Participate
Eligibility Criteria
You may qualify if you...
- The 4,094 residents of Shanghai communities who have been enrolled in the STONE cohort.
- Individuals who completed the baseline questionnaire survey, physical examination, and related clinical tests between 2016 and 2017, with complete data records.
- Willingness to participate in this follow-up study and provision of informed consent.
You will not qualify if you...
- Participants who have moved away from their original community and have been living elsewhere for more than two years.
- Participants whose contact information has changed or become invalid, resulting in loss of contact (those who remain uncontactable after three attempts to reach out).
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 1 year (2016 to 2017)
Participants complete baseline questionnaires, physical examinations, and clinical tests to collect demographic, lifestyle, physical, metabolic, and ultrasound imaging data.
1 baseline visit (in-person)
Duration - Up to 10 years
Participants are followed over time to observe the development of cardiovascular and metabolic diseases.
Follow-up contact and assessments as scheduled over 10 years
Trial Site Locations
Total: 1 location
1
Shanghai Changzheng Hospital
Shanghai, Shanghai Municipality, China, 200003
Actively Recruiting
Research Team
T
tuo Tuo Li, Doctor
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here